Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination



Rating:

Share or cite this content

Citations should be made in the following way:
G. Sotgiu (Sassari, Italy), G. B. Migliori (Tradate, Italy). TB/HIV management: what is new?. School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination

Member's Comments

No comment yet.

Related content which might interest you: MDR-TB management: what is new? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Integrated care: a new model for COPD management? Source: Eur Respir J 2006; 28: 4-6 Year: 2006 Optimising COPD prevention: what do the doctors need? Source: Annual Congress 2007 - Smoking and the lung Year: 2007 Nutritional interventions and rehabilitation programmes in COPD: what is new? Source: Annual Congress 2013 –New insights into the mechanisms of muscle dysfunction in COPD Year: 2013 Digital health technology for the end TB strategy: Developing priority products and making them work Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Crowdfunding for respiratory research: a new frontier for patient and public engagement? Source: Eur Respir J, 50 (4) 1701333; 10.1183/13993003.01333-2017 Year: 2017 How does primary health care providers‘ pre-knowledge on tuberculosis affect the implementation of DOTS strategy in Serbia? Source: Eur Respir J 2006; 28: Suppl. 50, 19s Year: 2006 Integration of care pathways for HIV-tuberculosis coinfection: a public health agenda Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 Response to pulmonary rehabilitation: toward personalised programmes? Source: Eur Respir J 2015; 46: 1538-1540 Year: 2015 What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis Source: Eur Respir Monogr 2018; 82: 414-429 Year: 2018 Closing the gap in surveillance of tuberculosis and HIV co-infection: a European perspective on the need for clinician–public health alliances Source: Eur Respir J, 50 (5) 1701758; 10.1183/13993003.01758-2017 Year: 2017 Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation Source: Eur Respir J 2014; 44: 1412-1417 Year: 2014 Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Source: Eur Respir J 2013; 42: 1449-1453 Year: 2013 Need to prioritise: end-of-life decision-making in India Source: Eur Respir J 2008; 31: 222-223 Year: 2008 Future of eHealth in TB management: perspectives of patients and medical staff Source: Virtual Congress 2021 – Digital innovations in tuberculosis and implementation research in the era of COVID-19: collaborative activities between the WHO and ERS Year: 2021 Implementing smoking cessation strategies in primary health care in Russia: Opportunities and challenges Source: Annual Congress 2012 - Tobacco use and cessation Year: 2012 MDR-/XDR-TB: what are the unresolved problems in the clinical management? Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET) Year: 2012 MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020 Tuberculosis elimination, patients' lives and rational use of new drugs: revisited Source: Eur Respir J 2016; 47: 664-667 Year: 2016